loading
Abeona Therapeutics Inc stock is traded at $4.68, with a volume of 1.24M. It is up +5.17% in the last 24 hours and down -10.69% over the past month. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
See More
Previous Close:
$4.45
Open:
$4.44
24h Volume:
1.24M
Relative Volume:
3.48
Market Cap:
$227.14M
Revenue:
-
Net Income/Loss:
$-54.19M
P/E Ratio:
-1.814
EPS:
-2.58
Net Cash Flow:
$-37.34M
1W Performance:
-6.21%
1M Performance:
-10.69%
6M Performance:
-24.88%
1Y Performance:
-37.43%
1-Day Range:
Value
$4.44
$4.915
1-Week Range:
Value
$4.4205
$5.1399
52-Week Range:
Value
$3.05
$8.45

Abeona Therapeutics Inc Stock (ABEO) Company Profile

Name
Name
Abeona Therapeutics Inc
Name
Phone
646-813-4701
Name
Address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Name
Employee
136
Name
Twitter
@abeonabio
Name
Next Earnings Date
2024-12-11
Name
Latest SEC Filings
Name
ABEO's Discussions on Twitter

Compare ABEO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ABEO
Abeona Therapeutics Inc
4.68 227.14M 0 -54.19M -37.34M -2.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-05-25 Initiated Oppenheimer Outperform
Jul-03-24 Initiated H.C. Wainwright Buy
May-30-24 Initiated Stifel Buy
Nov-11-20 Upgrade Cantor Fitzgerald Neutral → Overweight
Sep-18-20 Initiated B. Riley FBR Buy
Feb-10-20 Initiated SVB Leerink Outperform
Dec-10-19 Resumed Cantor Fitzgerald Neutral
Aug-15-19 Downgrade Maxim Group Buy → Hold
Aug-12-19 Downgrade Cantor Fitzgerald Overweight → Neutral
Jul-26-19 Downgrade Mizuho Buy → Neutral
Jun-27-19 Initiated Mizuho Buy
Oct-12-18 Initiated Mizuho Buy
Jun-05-18 Initiated Seaport Global Securities Buy
Nov-08-17 Initiated SunTrust Buy
Oct-16-17 Reiterated H.C. Wainwright Buy
Oct-11-17 Reiterated Cantor Fitzgerald Overweight
Oct-10-17 Initiated Citigroup Buy
Oct-05-17 Reiterated Maxim Group Buy
Sep-15-17 Initiated RBC Capital Mkts Outperform
Jul-18-17 Reiterated Maxim Group Buy
Jun-22-17 Resumed Jefferies Buy
Jan-06-17 Initiated Jefferies Buy
Sep-29-16 Reiterated Maxim Group Buy
View All

Abeona Therapeutics Inc Stock (ABEO) Latest News

pulisher
Apr 02, 2025

Breakeven On The Horizon For Abeona Therapeutics Inc. (NASDAQ:ABEO) - simplywall.st

Apr 02, 2025
pulisher
Apr 01, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 01, 2025
pulisher
Apr 01, 2025

Abeona Therapeutics Expands Team with Strategic Stock Grants for Key New Talent - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Abeona Therapeutics CEO sells shares worth $119,500 - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Abeona Therapeutics CEO sells shares worth $119,500 By Investing.com - Investing.com Australia

Mar 31, 2025
pulisher
Mar 28, 2025

Abeona Therapeutics (NASDAQ:ABEO) Upgraded by StockNews.com to Hold Rating - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

What is Zacks Small Cap’s Estimate for ABEO Q3 Earnings? - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

What is Zacks Small Cap’s Forecast for ABEO Q1 Earnings? - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

Equities Analysts Set Expectations for ABEO Q1 Earnings - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Trend Tracker for (ABEO) - news.stocktradersdaily.com

Mar 26, 2025
pulisher
Mar 26, 2025

What is HC Wainwright’s Forecast for ABEO Q1 Earnings? - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Abeona Therapeutics (NASDAQ:ABEO) Given Buy Rating at HC Wainwright - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

Abeona Therapeutics (NASDAQ:ABEO) Upgraded to Hold at StockNews.com - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Abeona Therapeutics: Positive Outlook Amid FDA Hopes - MSN

Mar 24, 2025
pulisher
Mar 22, 2025

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 22, 2025
pulisher
Mar 21, 2025

Abeona planning potential US launch of pz-cel to treat RDEB - Epidermolysis Bullosa News

Mar 21, 2025
pulisher
Mar 21, 2025

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... By GuruFocus - Investing.com Canada

Mar 21, 2025
pulisher
Mar 21, 2025

Abeona Therapeutics Reports 2024 Financial Results - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat By Investing.com - Investing.com UK

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics targets $2B revenue potential for pz-cel amid U.S. launch preparations - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Oppenheimer maintains Abeona Therapeutics Outperform rating - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics® Reports Full Year 2024 Financial - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

ABEONA THERAPEUTICS INC. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory - Bluefield Daily Telegraph

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Strengthens to $98M Cash Position as FDA Decision for Pz-cel Approaches - StockTitan

Mar 20, 2025
pulisher
Mar 16, 2025

(ABEO) On The My Stocks Page - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 14, 2025

Abeona Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 14, 2025
pulisher
Mar 10, 2025

Abeona Therapeutics at Leerink’s Global Healthcare Conference: Launch Plans for PZcell - Investing.com Canada

Mar 10, 2025
pulisher
Mar 10, 2025

Abeona Therapeutics (ABEO) Projected to Post Earnings on Monday - Defense World

Mar 10, 2025
pulisher
Mar 07, 2025

Abeona Therapeutics (NASDAQ:ABEO) Coverage Initiated at Oppenheimer - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Oppenheimer Initiates Coverage of Abeona Therapeutics (ABEO) with Outperform Recommendation - MSN

Mar 06, 2025
pulisher
Mar 05, 2025

This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Mar 05, 2025
pulisher
Mar 05, 2025

Oppenheimer Initiates Coverage of Abeona Therapeutics (LSE:0H7R) with Outperform Recommendation - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

Trading (ABEO) With Integrated Risk Controls - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 05, 2025

Oppenheimer sets Abeona stock Outperform with $16 target By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 04, 2025

Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

When Abeona Therapeutics Takes the Stage: CEO's Upcoming Leerink Conference Presentation - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

Abeona Therapeutics announces new employee inducement grants - Yahoo Finance

Mar 04, 2025
pulisher
Mar 03, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

How Abeona Therapeutics Is Structuring Compensation to Attract New Talent - StockTitan

Mar 03, 2025
pulisher
Feb 27, 2025

Abeona Therapeutics Insider Stock Sales Prove Timely As Market Valuation Descends To US$232m - Simply Wall St

Feb 27, 2025
pulisher
Feb 25, 2025

StockNews.com Downgrades Abeona Therapeutics (NASDAQ:ABEO) to Sell - MarketBeat

Feb 25, 2025
pulisher
Feb 22, 2025

How the (ABEO) price action is used to our Advantage - Stock Traders Daily

Feb 22, 2025
pulisher
Feb 21, 2025

Cell and Gene Therapies in Rare Disorders Market to Skyrocket Across the 7MM During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.

Feb 21, 2025
pulisher
Feb 21, 2025

Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Down 6.8% in January - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

HC Wainwright Reaffirms "Buy" Rating for Abeona Therapeutics (NASDAQ:ABEO) - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Abeona Therapeutics’ (ABEO) Buy Rating Reaffirmed at HC Wainwright - Defense World

Feb 20, 2025
pulisher
Feb 18, 2025

Epidermolysis Bullosa Market Expected to rise, 2034 | Amryt - openPR

Feb 18, 2025

Abeona Therapeutics Inc Stock (ABEO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Cap:     |  Volume (24h):